The patent implications of China’s generics push
Innovator drug companies will face challenges but complementary guidelines benefiting innovators, including a potential five-year patent term extension, may pacify concerns
China’s State Council has announced new guidelines aimed at encouraging more and better quality generics in the market.
One of the most welcomed features by generics is that corporate income tax has been reduced to 15%, down from the...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.